SYTL2, synaptotagmin like 2, 54843

N. diseases: 58; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.020 Biomarker disease BEFREE Therefore, SLP-2 is expected to be an effective biomarker for targeted treatment and prognosis of ovarian tumor. 30944651 2019
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.020 Biomarker disease BEFREE Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer. 27220283 2016